TILT

TILT Holdings Crowned a NECANN Cup Winner Third Year in a Row

Retrieved on: 
Monday, March 25, 2024

PHOENIX, March 25, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (Cboe: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced today that its subsidiary Standard Farms won first place for best vape cartridge in the 2024 NECANN Cup with the Mimosa Liquid Live Rosin “All-in-One” Vape using the Jupiter/CCELL Voca Pro hardware.

Key Points: 
  • PHOENIX, March 25, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (Cboe: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced today that its subsidiary Standard Farms won first place for best vape cartridge in the 2024 NECANN Cup with the Mimosa Liquid Live Rosin “All-in-One” Vape using the Jupiter/CCELL Voca Pro hardware.
  • “Being awarded the best vape product at one of the nation’s leading cannabis competitions with our sought-after Mimosa live rosin strain helps solidify TILT’s position as an industry leader in product and hardware innovation,” said Tim Conder, Chief Executive Officer of TILT.
  • “Our team deserves recognition for their commitment to delivering the best cannabis products across the markets we serve.”
    Standard Farms’ Voca Pro Liquid Live Rosin "All-In-One" Vape combines the functionality of a high-quality hardware device with the potency and efficacy of a solventless cannabis input material.
  • Massachusetts patients and consumers can find Standard Farms products in-store at any of the Commonwealth Alternative Care , Inc. locations across the state or place an online order for pick-up or delivery at commonwealthaltcare.org .

TILT Holdings Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, March 14, 2024

In the fourth quarter, we experienced one of the largest periods of order volume in Jupiter’s history ahead of Chinese New Year.

Key Points: 
  • In the fourth quarter, we experienced one of the largest periods of order volume in Jupiter’s history ahead of Chinese New Year.
  • A portion of these Chinese New Year orders were delivered in the first quarter of 2024, which negatively impacted revenue and profitability for the fourth quarter of 2023.
  • These results include a non-cash impairment charge of $7.5 million in the fourth quarter of 2023, as well as a $54.6 million [non-cash] impairment charge in the fourth quarter of 2022.
  • Revenue was $166.0 million in the twelve months ended December 31, 2023, compared to $174.2 million in the prior year.

TILT Holdings Announces New Brand Partnership with LEVEL to Bring Their Cannabis Tablets to Pennsylvania

Retrieved on: 
Wednesday, March 13, 2024

PHOENIX, March 13, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT ) (OTCQB: TLLTF ), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced a new brand partnership to distribute LEVEL ’s targeted, effects-based infused tablets to patients in Pennsylvania.

Key Points: 
  • PHOENIX, March 13, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT ) (OTCQB: TLLTF ), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced a new brand partnership to distribute LEVEL ’s targeted, effects-based infused tablets to patients in Pennsylvania.
  • “Partnering with LEVEL to bring their products to market in Pennsylvania expands TILT’s offerings in a meaningful way for medical patients.
  • We love that these oral tablets are portable, discreet, and allow for dialed-in dosing.” said Tim Conder, Chief Executive Officer of TILT.
  • Together, TILT and LEVEL are opening doors to forge new possibilities for medical cannabis consumers.”
    “LEVEL is thrilled to bring a best-in-class, highly effective, long-lasting tablet to Pennsylvania through our partnership with TILT.

Parental avoidance of toxic exposures could help prevent autism, ADHD in children, new study shows

Retrieved on: 
Thursday, March 28, 2024

SAN ANTONIO, March 27, 2024 /PRNewswire-PRWeb/ -- Autism and attention deficit hyperactivity disorder (ADHD) may be preventable if parents avoid toxic exposures and adopt interventions such as environmental house calls, according to a published study led by researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio).

Key Points: 
  • The findings build on a 2015 study by UT Health San Antonio that first linked chemical intolerance in patients with the risk of their children developing autism and ADHD.
  • "Up to now, most interventions have been behavioral or medical, after a child is diagnosed."
  • Still, they wrote, "The implications of this study, if confirmed, could be significant for preventive measures and early intervention strategies in families with parental chemical intolerance.
  • And the prevalence of ADHD has risen to one in eight children, also according to the CDC.

TILT Sets Fourth Quarter and Full Year 2023 Conference Call for March 14 at 5:00 p.m. ET

Retrieved on: 
Tuesday, February 20, 2024

PHOENIX, Feb. 20, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc .

Key Points: 
  • PHOENIX, Feb. 20, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc .
  • The Company’s results will be reported in a press release prior to the call.
  • TILT management will host the conference call, followed by a question-and-answer period.
  • Interested parties can join the conference call by dialing in as directed below.

TILT Biotherapeutics Awarded USD 2M Grant from US Department of Defense for Ovarian Cancer Immunotherapy Research

Retrieved on: 
Wednesday, February 14, 2024

Ovarian cancer is a fatal disease with a pressing need for better therapies.

Key Points: 
  • Ovarian cancer is a fatal disease with a pressing need for better therapies.
  • TILT Biotherapeutics’ founder and CEO, Akseli Hemminki, a cancer clinician who has personally treated hundreds of cancer patients with oncolytic viruses, said, “We’re delighted to have been selected to receive our first U.S. grant.
  • Working closely with the Mayo Clinic, it will support our efforts to unleash the full potential of oncolytic adenoviruses in treating ovarian cancer.
  • *The work was supported by the Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, in the amount of $2,098,194.00, through the Ovarian Cancer Research Program under Award No.

TILT Holding’s Jupiter Research Introduces THREDZ, the Future of 510 Cartridges

Retrieved on: 
Monday, February 12, 2024

THREDZ is a stackable cartridge that prioritizes portability and personalization, allowing consumers to blend two oil cartridges to create the perfect fusion—and a customized experience.

Key Points: 
  • THREDZ is a stackable cartridge that prioritizes portability and personalization, allowing consumers to blend two oil cartridges to create the perfect fusion—and a customized experience.
  • This new technology from Jupiter Research empowers consumers to select two favorite strains and thread them together, creating bespoke blends from an endless variety of cannabinoid and terpene combinations.
  • Through Jupiter Research, TILT offers a diverse, inhalation-led product portfolio to consumers across the U.S. and abroad.”
    THREDZ cartridges integrate seamlessly with existing 510 batteries, one of the most widely used technologies for cannabis vapes, making it a sustainable and cost-efficient option for consumers.
  • To keep up-to-date, follow TILT and Jupiter Research on social media:

Travis Barker Launches Barker Canna Co. with Hardware Partner Jupiter Research

Retrieved on: 
Tuesday, February 6, 2024

LOS ANGELES, Feb. 06, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (CBOE: TILT ) (OTCQB: TLLTF ), a global provider of cannabis business solutions and parent company of Jupiter Research , the premier source for performance-driven wholesale cartridges, power supplies and all-in-ones vaporizers, today announced a hardware partnership with Travis Barker’s new cannabis company, Barker Canna Co .

Key Points: 
  • LOS ANGELES, Feb. 06, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (CBOE: TILT ) (OTCQB: TLLTF ), a global provider of cannabis business solutions and parent company of Jupiter Research , the premier source for performance-driven wholesale cartridges, power supplies and all-in-ones vaporizers, today announced a hardware partnership with Travis Barker’s new cannabis company, Barker Canna Co .
  • Barker Canna Co. is a vegan, cruelty-free cannabis brand created by renowned musician Travis Barker.
  • Now available at The Syndicate and other select dispensaries throughout California, the brand has plans to expand into additional legalized states this year.
  • “Jupiter’s established reputation as an innovative, trusted supplier of inhalation products made this partnership with Barker Canna Co. a natural fit,” said Tim Conder, CEO of TILT.

TILT Holdings Enters into Debt and Security Agreement with Smoore Technology Limited

Retrieved on: 
Wednesday, January 31, 2024

(“TILT" or the “Company”) ( Cboe:TILT ) ( OTCQB: TLLTF ), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced that the Company and each of its subsidiaries (collectively, the “TILT Companies”) have entered into a Debt and Security Agreement, Guaranty, and related collateral security documents (collectively, the “Agreements”) with Smoore Technology Limited (“Smoore”), effective January 28, 2024.

Key Points: 
  • (“TILT" or the “Company”) ( Cboe:TILT ) ( OTCQB: TLLTF ), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced that the Company and each of its subsidiaries (collectively, the “TILT Companies”) have entered into a Debt and Security Agreement, Guaranty, and related collateral security documents (collectively, the “Agreements”) with Smoore Technology Limited (“Smoore”), effective January 28, 2024.
  • The Agreements expand the Company and Jupiter Research, LLC’s (“Jupiter”) existing trade payable credit line with Smoore.
  • Pursuant to the terms of the Agreements, Smoore will continue to make sales of CCELL vape hardware products and ship on credit to TILT’s wholly-owned subsidiary Jupiter.
  • The guarantee provided by the TILT Companies under the Agreements enables TILT to increase and secure the credit line to support customer demand and will be secured by TILT’s grant of a first lien security interest in all TILT assets.

Scotiabank named one of Canada's Top Employers for Young People

Retrieved on: 
Wednesday, January 24, 2024

TORONTO, Jan. 24, 2024 /CNW/ - Scotiabank is pleased to be named as one of Canada's Top Employers for Young People 2024 by Mediacorp Canada Inc. for the fourth consecutive year.

Key Points: 
  • TORONTO, Jan. 24, 2024 /CNW/ - Scotiabank is pleased to be named as one of Canada's Top Employers for Young People 2024 by Mediacorp Canada Inc. for the fourth consecutive year.
  • To provide young people the skills they need to develop and thrive in the workplace, Scotiabank offers comprehensive learning through the Talent Incubators for Leaders of Tomorrow (TILT) program.
  • Since launching in 2021, over 1,000 graduates have participated in TILT programs, with more than 200 young people completing the programs last year.
  • Now in its 22nd year, Canada's Top Employers for Young People is an editorial competition that recognizes the employers that offer the nation's best workplaces and programs for young people starting their careers.